keyword
https://read.qxmd.com/read/32756454/macropinocytosis-in-different-cell-types-similarities-and-differences
#21
REVIEW
Xiao Peng Lin, Justine D Mintern, Paul A Gleeson
Macropinocytosis is a unique pathway of endocytosis characterised by the nonspecific internalisation of large amounts of extracellular fluid, solutes and membrane in large endocytic vesicles known as macropinosomes. Macropinocytosis is important in a range of physiological processes, including antigen presentation, nutrient sensing, recycling of plasma proteins, migration and signalling. It has become apparent in recent years from the study of specialised cells that there are multiple pathways of macropinocytosis utilised by different cell types, and some of these pathways are triggered by different stimuli...
August 3, 2020: Membranes
https://read.qxmd.com/read/32747505/ubiquitination-of-mhc-class-ii-is-required-for-development-of-regulatory-but-not-conventional-cd4-t-cells
#22
JOURNAL ARTICLE
Haiyin Liu, Kayla R Wilson, Patrick Schriek, Christophe Macri, Annabelle B Blum, Lauren Francis, Melanie Heinlein, Champa Nataraja, James Harris, Sarah A Jones, Daniel H D Gray, Jose A Villadangos, Justine D Mintern
MHC class II (MHC II) displays peptides at the cell surface, a process critical for CD4+ T cell development and priming. Ubiquitination is a mechanism that dictates surface MHC II with the attachment of a polyubiquitin chain to peptide-loaded MHC II, promoting its traffic away from the plasma membrane. In this study, we have examined how MHC II ubiquitination impacts the composition and function of both conventional CD4+ T cell and regulatory T cell (Treg ) compartments. Responses were examined in two models of altered MHC II ubiquitination: MHCIIKRKI /KI mice that express a mutant MHC II unable to be ubiquitinated or mice that lack membrane-associated RING-CH 8 (MARCH8), the E3 ubiquitin ligase responsible for MHC II ubiquitination specifically in thymic epithelial cells...
August 3, 2020: Journal of Immunology
https://read.qxmd.com/read/32319148/covid-19-searching-for-clues-among-other-respiratory-viruses
#23
EDITORIAL
Catriona Nguyen-Robertson, Ashraful Haque, Justine Mintern, Anne C La Flamme
No abstract text is available yet for this article.
April 2020: Immunology and Cell Biology
https://read.qxmd.com/read/32190325/the-amalgamation-of-cellular-metabolism-and-immunology-for-host-immunity
#24
EDITORIAL
Justine D Mintern, Katrina J Binger
No abstract text is available yet for this article.
2020: Clinical & Translational Immunology
https://read.qxmd.com/read/31191533/downregulation-of-mhc-class-i-expression-by-influenza-a-and-b-viruses
#25
JOURNAL ARTICLE
Marios Koutsakos, Hamish E G McWilliam, Turgut E Aktepe, Svenja Fritzlar, Patricia T Illing, Nicole A Mifsud, Anthony W Purcell, Steve Rockman, Patrick C Reading, Julian P Vivian, Jamie Rossjohn, Andrew G Brooks, Jason M Mackenzie, Justine D Mintern, Jose A Villadangos, Thi H O Nguyen, Katherine Kedzierska
Manipulation of the MHC-I presentation pathway, and thus limiting MHC-I cell surface expression, is used by many viruses to evade immune recognition. In particular, downregulation of MHC-I molecules at the cell surface can reduce the ability of CD8+ T cells to recognize viral peptides presented by MHC-I molecules and thereby delay viral clearance by CD8+ T cells. To date, MHC-I downregulation by influenza viruses has not been reported. Given that influenza virus infections are a global health concern and that CD8+ T cells play an important role in promoting influenza virus clearance and recovery from influenza disease, we investigated whether influenza A and B viruses (IAV, IBV) downregulated MHC-I as a novel mechanism to evade cellular immunity...
2019: Frontiers in Immunology
https://read.qxmd.com/read/31063934/march-ligases-in-immunity
#26
REVIEW
Haiyin Liu, Justine D Mintern, Jose A Villadangos
Membrane associated RING-CH (MARCH) ubiquitin ligases control the stability, trafficking and function of important immunoreceptors, including MHC molecules and costimulatory molecule CD86. Regulation of the critical antigen presenting molecule MHC II by MARCH1 and the control of MARCH1 expression by inflammatory stimuli is a key step in the function of antigen presenting cells. MHC II ubiquitination by MARCH8 and CD83 plays a critical role in T cell thymic selection. Recent studies reveal new immune functions of MARCH ligases in innate immunity, regulation of FcγR expression and Treg development...
May 4, 2019: Current Opinion in Immunology
https://read.qxmd.com/read/31012171/cancer-immunotherapy-advances-and-future-challenges
#27
EDITORIAL
Christophe Macri, Justine D Mintern
No abstract text is available yet for this article.
April 2019: Immunology and Cell Biology
https://read.qxmd.com/read/30979057/dendritic-cells-and-cancer-from-biology-to-therapeutic-intervention
#28
REVIEW
Ben Wylie, Christophe Macri, Justine D Mintern, Jason Waithman
Inducing effective anti-tumor immunity has become a major therapeutic strategy against cancer. Dendritic cells (DC) are a heterogenous population of antigen presenting cells that infiltrate tumors. While DC play a critical role in the priming and maintenance of local immunity, their functions are often diminished, or suppressed, by factors encountered in the tumor microenvironment. Furthermore, DC populations with immunosuppressive activities are also recruited to tumors, limiting T cell infiltration and promoting tumor growth...
April 11, 2019: Cancers
https://read.qxmd.com/read/30001419/march1-mediated-ubiquitination-of-mhc-ii-impacts-the-mhc-i-antigen-presentation-pathway
#29
JOURNAL ARTICLE
Kayla R Wilson, Haiyin Liu, Geraldine Healey, Vivian Vuong, Satoshi Ishido, Marco J Herold, Jose A Villadangos, Justine D Mintern
Major histocompatibility complex class II (MHC II) expression and turn-over are regulated via its ubiquitination by the membrane associated RING-CH 1 (MARCH1) E3 ligase. Unexpectedly, we show that MHC II ubiquitination also impacts MHC I. Lack of MARCH1 in B cells and dendritic cells (DCs) resulted in a significant reduction in surface MHC I expression. This decrease was not directly caused by changes in MARCH1 ubiquitination of MHC I but indirectly by altered MHC II trafficking in the absence of its ubiquitination...
2018: PloS One
https://read.qxmd.com/read/29776651/introduction-to-the-special-issue-nanomaterials-in-immunology
#30
EDITORIAL
Justine D Mintern, Angus P R Johnston
No abstract text is available yet for this article.
June 2018: Molecular Immunology
https://read.qxmd.com/read/29395251/the-potential-of-nanoparticle-vaccines-as-a-treatment-for-cancer
#31
REVIEW
David Urbanavicius, Tara Alvarez, Georgina K Such, Angus P R Johnston, Justine D Mintern
A complex and multifaceted relationship exists between cancer and the immune system. Advances in our understanding of this relationship have resulted in significant clinical attention in the possibilities of cancer immunotherapy. Harnessing the immune system's potent and selective destructive capability is a major focus of attempts to treat cancer. Despite significant progress in the field, cancer therapy still remains significantly deficient, with cancer being one of the largest contributors to morbidity and mortality in the developed world...
June 2018: Molecular Immunology
https://read.qxmd.com/read/28829049/the-march-family-joins-the-antigen-cross-presentation-party
#32
COMMENT
Justine D Mintern, José A Villadangos
No abstract text is available yet for this article.
October 2017: Immunology and Cell Biology
https://read.qxmd.com/read/28723546/local-modulation-of-antigen-presenting-cell-development-after-resolution-of-pneumonia-induces-long-term-susceptibility-to-secondary-infections
#33
JOURNAL ARTICLE
Antoine Roquilly, Hamish E G McWilliam, Cedric Jacqueline, Zehua Tian, Raphael Cinotti, Marie Rimbert, Linda Wakim, Irina Caminschi, Mireille H Lahoud, Gabrielle T Belz, Axel Kallies, Justine D Mintern, Karim Asehnoune, Jose A Villadangos
Lung infections cause prolonged immune alterations and elevated susceptibility to secondary pneumonia. We found that, after resolution of primary viral or bacterial pneumonia, dendritic cells (DC), and macrophages exhibited poor antigen-presentation capacity and secretion of immunogenic cytokines. Development of these "paralyzed" DCs and macrophages depended on the immunosuppressive microenvironment established upon resolution of primary infection, which involved regulatory T (Treg) cells and the cytokine TGF-β...
July 18, 2017: Immunity
https://read.qxmd.com/read/28019081/dna-based-probes-for-flow-cytometry-analysis-of-endocytosis-and-recycling
#34
JOURNAL ARTICLE
Claire Dumont, Ewa Czuba, Moore Chen, Jose A Villadangos, Angus P R Johnston, Justine D Mintern
The internalization of proteins plays a key role in cell development, cell signaling and immunity. We have previously developed a specific hybridization internalization probe (SHIP) to quantitate the internalization of proteins and particles into cells. Herein, we extend the utility of SHIP to examine both the endocytosis and recycling of surface receptors using flow cytometry. SHIP was used to monitor endocytosis of membrane-bound transferrin receptor (TFR) and its soluble ligand transferrin (TF). SHIP enabled measurements of the proportion of surface molecules internalized, the internalization kinetics and the proportion and rate of internalized molecules that recycle to the cell surface with time...
April 2017: Traffic
https://read.qxmd.com/read/27978488/antibody-mediated-targeting-of-antigen-to-c-type-lectin-like-receptors-clec9a-and-clec12a-elicits-different-vaccination-outcomes
#35
JOURNAL ARTICLE
Christophe Macri, Claire Dumont, Scott Panozza, Mireille H Lahoud, Irina Caminschi, Jose A Villadangos, Angus P R Johnston, Justine D Mintern
Targeting antigen (Ag) to dendritic cell (DC) surface receptors is a potential new mode of vaccination. C-type lectin-like receptors Clec9A and Clec12A are attractive receptor targets however their targeting in vivo elicits significantly different outcomes for unknown reasons. To gain insight into the mechanisms responsible, we have examined the intrinsic capacity of Clec9A and Clec12A to elicit MHC I and MHC II Ag presentation following ex vivo targeting with primary murine DC. Both receptors exhibited high rates of internalization by CD8+ DCs, while Clec12A delivered a significantly higher Ag owing to its higher expression level...
January 2017: Molecular Immunology
https://read.qxmd.com/read/27503069/ubiquitin-ligase-march-8-cooperates-with-cd83-to-control-surface-mhc-ii-expression-in-thymic-epithelium-and-cd4-t-cell-selection
#36
JOURNAL ARTICLE
Haiyin Liu, Reema Jain, Jing Guan, Vivian Vuong, Satoshi Ishido, Nicole L La Gruta, Daniel H Gray, Jose A Villadangos, Justine D Mintern
Major histocompatibility complex class II (MHC II) expression is tightly regulated, being subjected to cell type-specific mechanisms that closely control its levels at the cell surface. Ubiquitination by the E3 ubiquitin ligase MARCH 1 regulates MHC II expression in dendritic cells and B cells. In this study, we demonstrate that the related ligase MARCH 8 is responsible for regulating surface MHC II in thymic epithelial cells (TECs). March8(-/-) mice have elevated MHC II at the surface of cortical TECs and autoimmune regulator (AIRE)(-) medullary TECs (mTECs), but not AIRE(+) mTECs...
August 22, 2016: Journal of Experimental Medicine
https://read.qxmd.com/read/27217957/targeting-dendritic-cells-a-promising-strategy-to-improve-vaccine-effectiveness
#37
REVIEW
Christophe Macri, Claire Dumont, Angus Pr Johnston, Justine D Mintern
Dendritic cell (DC) targeting is a novel strategy to enhance vaccination efficacy. This approach is based on the in situ delivery of antigen via antibodies that are specific for endocytic receptors expressed at the surface of DCs. Here we review the complexity of the DC subsets and the antigen presentation pathways that need to be considered in the settings of DC targeting. We also summarize current knowledge about antigen delivery to DCs via DEC-205, Clec9A and Clec12A, receptor targets that strongly enhance cellular and humoral immune responses...
March 2016: Clinical & Translational Immunology
https://read.qxmd.com/read/27142019/analysis-of-intracellular-trafficking-of-dendritic-cell-receptors-for-antigen-targeting
#38
JOURNAL ARTICLE
Haiyin Liu, Claire Dumont, Angus P R Johnston, Justine D Mintern
Antibody-targeted vaccination aims to efficiently deliver antigen to dendritic cells by targeting specific receptors at the cell surface. The choice of receptor depends on different factors, including their capacity to induce internalization of the delivered antigen/adjuvant cargo. Assays currently used to monitor internalization in dendritic cells have several limitations. We have developed a novel DNA-based probe that allows for simple and robust high-throughput analysis of internalization. Designed for flow cytometry, the probe can also be used for fluorescence microscopy to clearly distinguish internalized from surface-bound material...
2016: Methods in Molecular Biology
https://read.qxmd.com/read/27043408/the-intracellular-pathway-for-the-presentation-of-vitamin-b-related-antigens-by-the-antigen-presenting-molecule-mr1
#39
JOURNAL ARTICLE
Hamish E G McWilliam, Sidonia B G Eckle, Alex Theodossis, Ligong Liu, Zhenjun Chen, Jacinta M Wubben, David P Fairlie, Richard A Strugnell, Justine D Mintern, James McCluskey, Jamie Rossjohn, Jose A Villadangos
The antigen-presenting molecule MR1 presents vitamin B-related antigens (VitB antigens) to mucosal-associated invariant T (MAIT) cells through an uncharacterized pathway. We show that MR1, unlike other antigen-presenting molecules, does not constitutively present self-ligands. In the steady state it accumulates in a ligand-receptive conformation within the endoplasmic reticulum. VitB antigens reach this location and form a Schiff base with MR1, triggering a 'molecular switch' that allows MR1-VitB antigen complexes to traffic to the plasma membrane...
May 2016: Nature Immunology
https://read.qxmd.com/read/27036915/target-density-not-affinity-or-avidity-of-antigen-recognition-determines-adoptive-t-cell-therapy-outcomes-in-a-mouse-lymphoma-model
#40
JOURNAL ARTICLE
Gabriela Segal, Sandro Prato, Dietmar Zehn, Justine D Mintern, Jose A Villadangos
Adoptive T cell therapy (ACT) with antitumor CTL is a promising and tailored treatment against cancer. We investigated the role played by the affinity and avidity of the interaction between the tumor and the CTL on the outcome of ACT against a mouse non-Hodgkin B cell lymphoma that expresses OVA as a model neoantigen. ACT was assessed under conditions where antitumor CTL expressed TCR of varying affinity for OVA. We also assessed conditions where the avidity of Ag recognition varied because the lymphoma cells expressed high or low levels of OVA...
May 1, 2016: Journal of Immunology
keyword
keyword
103836
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.